Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center

Abstract Background To explore risk factors and the efficacy of treatment strategies for brain metastasis (BM) in squamous cell carcinoma (SCC) of the lung. Methods The clinical data of 188 pathologically confirmed as squamous cell carcinoma or adenosquamous carcinoma patients were studied retrospec...

Full description

Bibliographic Details
Main Authors: Bo Li, Yanwei Liu, Shuai Liu, Xuenan Gu, Xiaoguang Qiu
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Chinese Neurosurgical Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41016-017-0096-1
_version_ 1818512650935468032
author Bo Li
Yanwei Liu
Shuai Liu
Xuenan Gu
Xiaoguang Qiu
author_facet Bo Li
Yanwei Liu
Shuai Liu
Xuenan Gu
Xiaoguang Qiu
author_sort Bo Li
collection DOAJ
description Abstract Background To explore risk factors and the efficacy of treatment strategies for brain metastasis (BM) in squamous cell carcinoma (SCC) of the lung. Methods The clinical data of 188 pathologically confirmed as squamous cell carcinoma or adenosquamous carcinoma patients were studied retrospectively. Factors including age (<60 vs. ≥60), gender, stage at diagnosis, T status (T1–2 vs. T3–4), N status (N0–1 vs. N2–3), histology (squamous vs. adenosquamous), smoking history (non-smoker vs. current smoker) and serum tumor markers (normal vs. elevated) were analyzed. Results The incidence of BM was 19.1% (36/188) in our cohort. Patients who were female (p = 0.005), had advanced disease at diagnosis (p < 0.001), had adenosquamous carcinoma histology (p = 0.033) or had elevated serum level of CEA at diagnosis (p < 0.001) had significantly higher incidence of BM. In multivariate analysis, female (p = 0.034, HR = 18.874) and elevated serum level of CEA at diagnosis (p = 0.009, HR = 19.824) were independent risk factors of BM. BM patients who received additional systemic therapy after local therapy had significantly longer post-BM survival than those who received local therapy only (p = 0.004, HR = 0.058). Gemcitabine/platinum-containing regimen (GP) and taxans/platinum-containing regimen (TP) led to comparable brain-metastasis-free survival (BMFS) (p = 0.10). Conclusions Females and patients with elevated serum level of CEA at diagnosis had a higher risk of developing BM. The following systemic therapy after local therapy prolonged the survival of BM patient, but the efficacy of GP and TP was comparable in terms of preventing BM.
first_indexed 2024-12-10T23:49:52Z
format Article
id doaj.art-260eec717f034f13aa9f636751100a37
institution Directory Open Access Journal
issn 2057-4967
language English
last_indexed 2024-12-10T23:49:52Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Chinese Neurosurgical Journal
spelling doaj.art-260eec717f034f13aa9f636751100a372022-12-22T01:28:48ZengBMCChinese Neurosurgical Journal2057-49672017-11-01311910.1186/s41016-017-0096-1Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single centerBo Li0Yanwei Liu1Shuai Liu2Xuenan Gu3Xiaoguang Qiu4Department of Radiation Oncology, Beijing Tiantan Hospital affiliated to Capital Medical UniversityDepartment of Radiation Oncology, Beijing Tiantan Hospital affiliated to Capital Medical UniversityDepartment of Radiation Oncology, Beijing Tiantan Hospital affiliated to Capital Medical UniversityDepartment of Radiation Oncology, Beijing Tiantan Hospital affiliated to Capital Medical UniversityDepartment of Radiation Oncology, Beijing Tiantan Hospital affiliated to Capital Medical UniversityAbstract Background To explore risk factors and the efficacy of treatment strategies for brain metastasis (BM) in squamous cell carcinoma (SCC) of the lung. Methods The clinical data of 188 pathologically confirmed as squamous cell carcinoma or adenosquamous carcinoma patients were studied retrospectively. Factors including age (<60 vs. ≥60), gender, stage at diagnosis, T status (T1–2 vs. T3–4), N status (N0–1 vs. N2–3), histology (squamous vs. adenosquamous), smoking history (non-smoker vs. current smoker) and serum tumor markers (normal vs. elevated) were analyzed. Results The incidence of BM was 19.1% (36/188) in our cohort. Patients who were female (p = 0.005), had advanced disease at diagnosis (p < 0.001), had adenosquamous carcinoma histology (p = 0.033) or had elevated serum level of CEA at diagnosis (p < 0.001) had significantly higher incidence of BM. In multivariate analysis, female (p = 0.034, HR = 18.874) and elevated serum level of CEA at diagnosis (p = 0.009, HR = 19.824) were independent risk factors of BM. BM patients who received additional systemic therapy after local therapy had significantly longer post-BM survival than those who received local therapy only (p = 0.004, HR = 0.058). Gemcitabine/platinum-containing regimen (GP) and taxans/platinum-containing regimen (TP) led to comparable brain-metastasis-free survival (BMFS) (p = 0.10). Conclusions Females and patients with elevated serum level of CEA at diagnosis had a higher risk of developing BM. The following systemic therapy after local therapy prolonged the survival of BM patient, but the efficacy of GP and TP was comparable in terms of preventing BM.http://link.springer.com/article/10.1186/s41016-017-0096-1Brain metastasisChemotherapyNon-small cell lung cancerRisk factorSquamous cell carcinoma
spellingShingle Bo Li
Yanwei Liu
Shuai Liu
Xuenan Gu
Xiaoguang Qiu
Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
Chinese Neurosurgical Journal
Brain metastasis
Chemotherapy
Non-small cell lung cancer
Risk factor
Squamous cell carcinoma
title Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
title_full Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
title_fullStr Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
title_full_unstemmed Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
title_short Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
title_sort risk factors of brain metastasis of lung squamous cell carcinoma a retrospective analysis of 188 patients from single center
topic Brain metastasis
Chemotherapy
Non-small cell lung cancer
Risk factor
Squamous cell carcinoma
url http://link.springer.com/article/10.1186/s41016-017-0096-1
work_keys_str_mv AT boli riskfactorsofbrainmetastasisoflungsquamouscellcarcinomaaretrospectiveanalysisof188patientsfromsinglecenter
AT yanweiliu riskfactorsofbrainmetastasisoflungsquamouscellcarcinomaaretrospectiveanalysisof188patientsfromsinglecenter
AT shuailiu riskfactorsofbrainmetastasisoflungsquamouscellcarcinomaaretrospectiveanalysisof188patientsfromsinglecenter
AT xuenangu riskfactorsofbrainmetastasisoflungsquamouscellcarcinomaaretrospectiveanalysisof188patientsfromsinglecenter
AT xiaoguangqiu riskfactorsofbrainmetastasisoflungsquamouscellcarcinomaaretrospectiveanalysisof188patientsfromsinglecenter